RxDoctor Payments Data

Jennifer Davis

Family · Mobile, ALNPI 1811342041

Payments from drug & device makers

$4,267in general payments, 2019–2025

Across 163 payments — averaging $26.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Globus Medical$282
  • Indivior Inc.$251
  • Forte Bio-pharma LLC$164
  • Collegium Pharmaceutical, Inc.$152
  • plus $880 from 18 others

What the payments were for

  • Travel & lodging$1,03724%
  • Food & beverage$3,19475%
  • Education$361%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,267 in reported general payments places this provider in the 85th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Medicare billing

Part B allowed, 2024
$65,202
Medicare patients
182
Services billed
2,086

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MovantikNaloxegol Oxalate30$13,247
Tizanidine Hcl666$5,783
Diclofenac Sodium148$4,749
Cyclobenzaprine Hcl487$4,308
Celecoxib179$3,272
Baclofen285$2,333
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl13$1,975
Chlorzoxazone52$1,873
Lidocaine21$1,526
Ibuprofen116$1,362
Duloxetine Hcl115$1,246
Methocarbamol127$1,109
Meloxicam267$776
Doxepin Hcl31$526
Topiramate82$400

Paid to pharmacies, not to this prescriber.

Other family in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →